Results 11 to 20 of about 25,511 (229)

The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015

Vaccines, 2022
Mumps and rubella are vaccine-preventable viral diseases through the measles-mumps-rubella-varicella (MMRV) vaccine, administered at 12 months and again at 6 years.
Ravit Bassal, Tamy Shohat, Tal Levin, Rakefet Pando, Eilat Shinar, Doron Amichay, Mira Barak, Anat Ben-Dor, Adina Bar-Haim, Ella Mendelson, Dani Cohen, Lital Keinan-Boker, Victoria Indenbaum   +12 more
doaj   +1 more source

Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries

Papillomavirus Research, 2019
Rubella vaccine was not part of national immunization programs (NIP) in several countries in the Middle East and North Africa (MENA), South-East Asia (SEA), and South Africa regions until the year 2000.
Asmaa Gohar, Nourtan F. Abdeltawab, Nahla Shehata, Magdy A. Amin   +3 more
doaj   +1 more source

Sero-epidemiology of rubella in the urban population of Addis Ababa Ethiopia [PDF]

, 2000
We conducted a community-based cluster sample survey of rubella sero-epidemiology in Addis Ababa, Ethiopia in 1994. Among 4666 individuals for whom complete data were available, rubella antibody prevalence was 91% (95% confidence interval: 90, 92).
Nigatu, Wondatir, Cutts, Felicity, Messele, T., Dejene, A., Nokes, D. James, Enquselassie, F., Abebe, A.   +6 more
core   +1 more source

Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda

BMC Infectious Diseases, 2020
Background Control of Rubella and Congenital Rubella Syndrome using vaccination has shown great success in the America’s. Uganda is due to introduce the Rubella vaccine however the magnitude of transmission is not well documented.
Fred Bagenda, Edgar Mugema Mulogo, Richard Onyuthi Apecu, Anette Kisakye, Benard Toliva Opar   +4 more
doaj   +1 more source

Biological properties of domestic strain vRub-Ant of rubella virus

Журнал микробиологии, эпидемиологии и иммунобиологии, 2022
Introduction. Rubella is a mild infectious disease affecting mainly children and is caused by the rubella virus, part of the Matonoviridae family, genus Rubivirus.
Firaya G. Nagieva, Elena P. Barkova, Alexandra D. Stroeva, Yulia I. Ammur, Alexander V. Sidorov, Olga S. Kharchenko, Georgy N. Bukhtoyarov, Oksana A. Svitich, Vitaly V. Zverev   +8 more
doaj   +1 more source

Reliability of medical students' vaccination histories for immunisable diseases [PDF]

, 2008
Background Medical students come into contact with infectious diseases early on their career. Immunity against vaccine-preventable diseases is therefore vital for both medical students and the patients with whom they come into contact.
René Gottschalk, Allwinn Regina, Allwinn, Regina, Gottschalk, René, Sabine Wicker, Regina Allwinn, Rabenau, Holger, Holger F Rabenau, Gottschalk René, Rabenau Holger F, Wicker, Sabine, Wicker Sabine   +11 more
core   +1 more source

A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. [PDF]

, 2001
BACKGROUND: An association between mumps-measles-rubella (MMR) vaccination and the onset of symptoms typical of autism has recently been suggested. This has led to considerable concern about the safety of the vaccine.
Andrew J Hall, Eric Fombonne, Fombonne, E, Fombonne Eric, Xiangning Huang, Huang, X, Smeeth Liam, Rodrigues, LC, Peter G Smith, Rodrigues Laura C, Liam Smeeth, Smith, PG, Smith Peter G, Laura C Rodrigues, Hall, AJ, Smeeth, L, Huang Xiangning, Hall Andrew J   +17 more
core   +1 more source

Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.

PLoS ONE, 2022
The Democratic Republic of the Congo (DRC) has a high measles incidence despite elimination efforts and has yet to introduce rubella vaccine. We evaluated the performance of a prototype rapid digital microfluidics powered (DMF) enzyme-linked immunoassay (
Alaine K Knipes, Aimee Summers, Alexandros A Sklavounos, Julian Lamanna, Richard P S de Campos, Tanya Narahari, Christopher Dixon, Ryan Fobel, Yassa D Ndjakani, Leopold Lubula, Alain Magazani, Jean Jacques Muyembe, Yvonne Lay, Elizabeth Pukuta, Diane Waku-Kouomou, Lijuan Hao, Jolie Kasongo Kayembe, Christian Fobel, Joshua Dahmer, Adam Lee, Man Ho, Jose Gilberto Camacho Valenzuela, Darius G Rackus, Roger Shih, Brendon Seale, Ann Chang, Gilson Paluku, Paul A Rota, Aaron R Wheeler, Heather M Scobie   +29 more
doaj   +1 more source

Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.

PLoS ONE, 2018
BackgroundMeasles outbreaks have occurred in some countries despite supplementary immunization activities (SIA) using measles-containing vaccine with high vaccination coverage.
Masahiko Hachiya, Shinsuke Miyano, Yoshio Mori, Emilia Vynnycky, Phath Keungsaneth, Phengta Vongphrachanh, Anonh Xeuatvongsa, Thongchanh Sisouk, Vilasak Som-Oulay, Bouaphan Khamphaphongphane, Bounthanom Sengkeopaseuth, Chansay Pathammavong, Kongxay Phounphenghak, Tomomi Kitamura, Makoto Takeda, Katsuhiro Komase   +15 more
doaj   +1 more source

Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study [PDF]

, 2002
OBJECTIVES: To investigate whether measles, mumps, and rubella (MMR) vaccination is associated with bowel problems and developmental regression in children with autism, looking for evidence of a "new variant" form of autism. DESIGN: Population study with
Andrews, N, Stowe, J, Andrews, Nick, Stowe, Julia, Miller, E, Miller, Elizabeth, Simmons, Andrea, Lingam, R, Simmons, A, Taylor, Brent, Taylor, B, Lingam, Raghu   +11 more
core   +1 more source